Sujal Patel is the cofounder and CEO of Nautilus Biotechnology which offers a high-throughput, low-cost platform for analyzing and quantifying the human proteome. The company has raised over $100 million from top tier investors such as Andreessen Horowitz, Madrona Venture Group, AME Cloud Ventures, Vulcan Capital, Perceptive Advisors, Bezos Expeditions, Bolt Ventures, and Defy Ventures to name a few.  Prior to this, he cofounded Isilon which he sold to EMC for $2.6 billion.